Exact Sciences Q4 screening revenue up 61 percent
Exact Sciences brought in about $230 million in screening revenue during the fourth quarter of last year, according to the company’s latest preliminary financial report....
15 January, 2020
Resident Company News
Arrowhead Pharmaceuticals makes $267 million public stock offering
A $267 million stock offering last week by Arrowhead Pharmaceuticals, which has its main employment base in Madison, could help the company bring experimental drugs to market and lead to the purchase of other businesses....
08 December, 2019
DR. DAVID AHLQUIST, CO-INVENTOR OF COLOGUARD, NAMED A FELLOW OF THE NATIONAL ACADEMY OF INVENTORS
Exact Sciences announced Dr. David Ahlquist, co-inventor of Cologuard® has been named a Fellow of the National Academy of Inventors (NAI)....
05 December, 2019
Legislature passes bills related to startup funding, oversight
The state Legislature has passed several bills championed by the Wisconsin Technology Council that would change state laws surrounding startup funding and oversight. ...
18 November, 2019
Exact Sciences could double Cologuard lab space along Beltline
Even before current construction is finished, Exact Sciences is planning for another stage of expansion at one of its Madison campuses, which could about double its lab space....
14 November, 2019
Meet the 3 Startups That Took Home Trophies at Wisconsin Tech Council’s Pitch Olympics
Eighteen state startups took to the stage to pitch their companies during lightning rounds at the Elevator Pitch Olympics in Madison. The annual competition was part of the Wisconsin Early Stage Symposium, a two-day event put on by the Wisconsin Technology Council....
14 November, 2019
Here are the first four investments from Venture Investors’ new $75M health VC fund
Invenra Inc., a Madison startup that developed a drug discovery platform to identify human multi-specific antibodies for immuno-oncology, is one of the four startups to receive an investment from Wisconsin's Venture Investors....
06 October, 2019
Better transit is key to keeping Madison strong, tackling challenges
Here are three reasons why investing in BRT, a high-frequency, high-capacity, limited-stop bus service, must be a critical economic development priority:...
28 September, 2019
FDA Decision Expands Market for Exact Sciences’ Cologuard Test
The FDA has approved the test, Cologuard, for eligible, average-risk patients ages 45 and older, which expands the market that Madison, WI-based Exact can address with its product....
23 September, 2019
Mallinckrodt Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft® Regenerative Tissue
The study, which met both primary endpoints, evaluated the efficacy and safety of a single application of StrataGraft in the treatment of deep partial-thickness thermal burns....
23 September, 2019